FDA Adverse Event Injury Summary report: N

UNKNOWN COOLSCULPTING SYSTEM

MDR report key: 14432095 · Received May 18, 2022

Report

Report Number
3007215625-2022-00745
Event Type
Injury
Date Received
May 18, 2022
Date of Event
April 25, 2022
Report Date
June 10, 2024
Manufacturer
ALLERGAN PLEASANTON
Product Code
OOK
PMA / PMN Number
K160259
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NC, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

ACCORDING TO THE COOLSCULPTING USER MANUAL, UNDER RARE ADVERSE EVENTS, PARADOXICAL ADIPOSE HYPERPLASIA (PH/PAH) IS CHARACTERIZED BY A VISIBLY ENLARGED TISSUE VOLUME WITHIN THE TREATMENT AREA, WHICH MAY DEVELOP TWO TO FIVE MONTHS AFTER TREATMENT. SURGICAL INTERVENTION MAY BE REQUIRED. PAH IS NOT RELATED TO ANY COOLSCULPTING DEVICE FAILURE MODE BUT IT IS INCLUDED IN THE RISK MANAGEMENT FILES OF THE DEVICE BECAUSE IT IS A RISK THAT IS INHERENT TO THE USE CRYOLIPOLYSIS FOR LOCALIZED FAT REDUCTION. A SUPPLEMENTAL REPORT WILL BE SUBMITTED IF AND WHEN ADDITIONAL INFORMATION IS OBTAINED.

Additional Manufacturer Narrative · 0

ADDITIONAL, CHANGED, AND/OR CORRECTED DATA: AWARE DATE. H11: CORRECTED DATA: SUBSEQUENT TO THE SUBMISSION OF INITIAL MEDWATCH, THIS REPORT HAS BEEN IDENTIFIED AS A DUPLICATE OF PREVIOUSLY SUBMITTED MEDWATCH REPORT OF 3007215625-2022-00726-00.

Additional Manufacturer Narrative · 0

CORRECTED DATA: D1, G1 AND H6.

Description of Event or Problem · 0

ALLERGAN AESTHETICS RECEIVED A REPORT OF A PATIENT ABDOMEN AND FLANKS TREATED WITH COOLSCULPTING DEVELOPED PARADOXICAL HYPERPLASIA (PAH/PH).

Description of Event or Problem · 0

SUBSEQUENT TO THE SUBMISSION OF INITIAL MEDWATCH, THIS REPORT HAS BEEN IDENTIFIED AS A DUPLICATE OF PREVIOUSLY SUBMITTED MEDWATCH REPORT OF 3007215625-2022-00726-00.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2606178 UNKNOWN COOLSCULPTING SYSTEM DERMAL COOLING PACK/VACUUM/MASSAGER OOK ALLERGAN PLEASANTON NI

Patients

Seq Age Sex Outcome Treatment
1 41 YR Unknown Required Intervention